Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease.

Gencer B, Mach F.

Drugs. 2020 Jan 9. doi: 10.1007/s40265-019-01243-5. [Epub ahead of print] Review.

PMID:
31916186
2.

Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort.

Gencer B, Carballo D, Nanchen D, Koskinas KC, Klingenberg R, Räber L, Auer R, Carballo S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F.

Int J Cardiol. 2019 Dec 10. pii: S0167-5273(19)34792-8. doi: 10.1016/j.ijcard.2019.12.011. [Epub ahead of print]

PMID:
31859113
3.

Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes.

Mahendiran T, Nanchen D, Gencer B, Meier D, Klingenberg R, Räber L, Carballo D, Matter CM, Lüscher TF, Windecker S, Mach F, Rodondi N, Muller O, Fournier S.

J Cardiovasc Transl Res. 2019 Nov 25. doi: 10.1007/s12265-019-09934-w. [Epub ahead of print]

PMID:
31768948
4.

Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation.

Pagano S, Magenta A, D'Agostino M, Martino F, Barillà F, Satta N, Frias MA, Ronca A, Mach F, Gencer B, Favari E, Vuilleumier N.

J Clin Med. 2019 Nov 21;8(12). pii: E2035. doi: 10.3390/jcm8122035.

5.

Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.

Winzap P, Davies A, Klingenberg R, Obeid S, Roffi M, Mach F, Räber L, Windecker S, Templin C, Nietlispach F, Nanchen D, Gencer B, Muller O, Matter CM, von Eckardstein A, Lüscher TF.

Cardiovasc Diabetol. 2019 Oct 31;18(1):142. doi: 10.1186/s12933-019-0946-6.

6.

Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors.

Butty A, Gencer B, Koskinas KC, Carballo D, Räber L, Klingenberg R, Matter CM, Lüscher TF, Windecker S, Muller O, Rodondi N, Mach F, Nanchen D.

Int J Cardiol. 2020 Jan 15;299:289-295. doi: 10.1016/j.ijcard.2019.10.012. Epub 2019 Oct 9.

PMID:
31668506
7.

Right ventricle and outcome in left ventricular non-compaction cardiomyopathy.

Stämpfli SF, Donati TG, Hellermann J, Anwer S, Erhart L, Gruner C, Kaufmann BA, Gencer B, Haager PK, Müller H, Tanner FC.

J Cardiol. 2020 Jan;75(1):20-26. doi: 10.1016/j.jjcc.2019.09.003. Epub 2019 Oct 4.

PMID:
31587941
8.

Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS).

Koskinas KC, Windecker S, Pedrazzini G, Mueller C, Cook S, Matter CM, Muller O, Häner J, Gencer B, Crljenica C, Amini P, Deckarm O, Iglesias JF, Räber L, Heg D, Mach F.

J Am Coll Cardiol. 2019 Nov 19;74(20):2452-2462. doi: 10.1016/j.jacc.2019.08.010. Epub 2019 Aug 31.

PMID:
31479722
9.

Gender Specificity and Interpretation of Functional Cardiac Imaging: Let's Talk about Sex.

Gencer B, Mach F.

Thromb Haemost. 2019 Sep;119(9):1379-1381. doi: 10.1055/s-0039-1695010. Epub 2019 Sep 1. No abstract available.

PMID:
31473990
10.

Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.

Vuilleumier N, Pagano S, Combescure C, Gencer B, Virzi J, Räber L, Carballo D, Carballo S, Nanchen D, Rodondi N, Windecker S, Hazen SL, Wang Z, Li XS, von Eckardstein A, Matter CM, Lüscher TF, Klingenberg R, Mach F.

J Clin Med. 2019 Jul 9;8(7). pii: E1002. doi: 10.3390/jcm8071002.

11.

Is male gender a prognostic factor for developmental dysplasia of the hip? Mid-long-term results of posteromedial limited surgery.

Dogan O, Caliskan E, Gencer B, Bicimoglu A.

Acta Orthop Traumatol Turc. 2019 Sep;53(5):340-345. doi: 10.1016/j.aott.2019.05.001. Epub 2019 Jul 4.

12.

Prognostic value of total testosterone levels in patients with acute coronary syndromes.

Gencer B, Vuilleumier N, Nanchen D, Collet TH, Klingenberg R, Räber L, Auer R, Carballo D, Carballo S, Aghlmandi S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F.

Eur J Prev Cardiol. 2019 Jun 1:2047487319853343. doi: 10.1177/2047487319853343. [Epub ahead of print]

PMID:
31154826
13.

Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleeding.

Nanchen D, Klingenberg R, Gencer B, Räber L, Carballo D, von Eckardstein A, Windecker S, Rodondi N, Lüscher TF, Mach F, Muller O, Matter CM.

Int J Cardiol. 2019 Jul 15;287:13-18. doi: 10.1016/j.ijcard.2019.03.049. Epub 2019 Mar 27.

PMID:
31003794
14.

Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study.

Jaquet E, Gencer B, Auer R, Moschetti K, Muller O, Matter CM, Lüscher TF, Mach F, Rodondi N, Bodenmann P, Nanchen D.

Swiss Med Wkly. 2019 Apr 17;149:w20049. doi: 10.4414/smw.2019.20049. eCollection 2019 Apr 8.

15.

Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.

Gencer B, Rigamonti F, Nanchen D, Vuilleumier N, Kern I, Aghlmandi S, Klingenberg R, Räber L, Auer R, Carballo D, Carballo S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F.

Eur J Clin Invest. 2019 Jul;49(7):e13117. doi: 10.1111/eci.13117. Epub 2019 May 7.

PMID:
30937890
16.

Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort.

Gencer B, Pagano S, Vuilleumier N, Satta N, Delhumeau-Cartier C, Meier C, Bavamian S, Montecucco F, Mach F, Calmy A.

Atherosclerosis. 2019 May;284:253-259. doi: 10.1016/j.atherosclerosis.2019.02.015. Epub 2019 Feb 20.

PMID:
30827714
17.

Efficacy of Sunitinib, Sunitinib-Hesperetin, and Sunitinib-Doxycycline Combinations on Experimentally-Induced Corneal Neovascularization.

Ekim Y, Kara S, Gencer B, Karaca T.

Curr Eye Res. 2019 Jun;44(6):590-598. doi: 10.1080/02713683.2019.1584320. Epub 2019 Mar 8.

PMID:
30803276
18.

Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.

Carballo D, Rodondi N, Auer R, Carballo S, Nanchen D, Räber L, Klingenberg R, Keller PF, Heg D, Jüni P, Muller O, Matter CM, Lüscher TF, Windecker S, Mach F, Gencer B.

PLoS One. 2019 Feb 21;14(2):e0211464. doi: 10.1371/journal.pone.0211464. eCollection 2019.

19.

Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial.

Koskinas KC, Windecker S, Buhayer A, Gencer B, Pedrazzini G, Mueller C, Cook S, Muller O, Matter CM, Räber L, Heg D, Mach F; EVOPACS Investigators.

Clin Cardiol. 2018 Dec;41(12):1513-1520. doi: 10.1002/clc.23112. Epub 2018 Nov 26.

20.

Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.

Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):16-24. doi: 10.1002/ccd.27712. Epub 2018 Oct 5.

PMID:
30291678
21.

Prognostic value of pulse pressure after an acute coronary syndrome.

Harbaoui B, Nanchen D, Lantelme P, Gencer B, Heg D, Klingenberg R, Räber L, Carballo D, Matter CM, Windecker S, Mach F, Rodondi N, Eeckhout E, Monney P, Antiochos P, Schwitter J, Pascale P, Fournier S, Courand PY, Lüscher TF, Muller O.

Atherosclerosis. 2018 Oct;277:219-226. doi: 10.1016/j.atherosclerosis.2018.07.013. Epub 2018 Jul 20.

PMID:
30033338
22.

Lipid management in ACS: Should we go lower faster?

Gencer B, Mach F.

Atherosclerosis. 2018 Aug;275:368-375. doi: 10.1016/j.atherosclerosis.2018.06.871. Epub 2018 Jun 22. Review.

PMID:
30015301
23.

Lipoprotein(a): the perpetual supporting actor.

Gencer B, Mach F.

Eur Heart J. 2018 Jul 14;39(27):2597-2599. doi: 10.1093/eurheartj/ehy385. No abstract available.

24.

Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes.

Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Roffi M, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W.

Int J Cardiol. 2018 Nov 1;270:7-13. doi: 10.1016/j.ijcard.2018.05.134. Epub 2018 Jun 1.

PMID:
29885826
25.

Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study.

Gencer B, Rigamonti F, Nanchen D, Klingenberg R, Räber L, Moutzouri E, Auer R, Carballo D, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F, Roffi M.

Eur Heart J Acute Cardiovasc Care. 2018 Jun 1:2048872618777819. doi: 10.1177/2048872618777819. [Epub ahead of print]

PMID:
29862825
26.

Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.

Blum MR, Gencer B, Adam L, Feller M, Collet TH, da Costa BR, Moutzouri E, Dopheide J, Depairon M, Sykiotis GP, Kearney P, Gussekloo J, Westendorp R, Stott DJ, Bauer DC, Rodondi N.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2988-2997. doi: 10.1210/jc.2018-00279.

PMID:
29846630
27.

Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.

Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, März W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Stein EA, Stroes ES, Thompson PD, Tokgözoglu L, Vladutiu GD, Gencer B, Stock JK, Ginsberg HN, Chapman MJ; European Atherosclerosis Society Consensus Panel.

Eur Heart J. 2018 Jul 14;39(27):2526-2539. doi: 10.1093/eurheartj/ehy182. Review.

28.

Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.

Koskinas KC, Zanchin T, Klingenberg R, Gencer B, Temperli F, Baumbach A, Roffi M, Moschovitis A, Muller O, Tüller D, Stortecky S, Mach F, Lüscher TF, Matter CM, Pilgrim T, Heg D, Windecker S, Räber L.

J Am Heart Assoc. 2018 Apr 13;7(8). pii: e008085. doi: 10.1161/JAHA.117.008085.

29.

Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.

Canivell S, Muller O, Gencer B, Heg D, Klingenberg R, Räber L, Carballo D, Matter C, Lüscher T, Windecker S, Mach F, Rodondi N, Nanchen D.

PLoS One. 2018 Apr 12;13(4):e0195174. doi: 10.1371/journal.pone.0195174. eCollection 2018.

30.

Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary Syndrome.

Obeid S, Yousif N, Schelldorfer A, Shahin M, Räber L, Gencer B, Mach F, Roffi M, Matter CM, Windecker S, Lüscher TF.

J Invasive Cardiol. 2018 Mar;30(3):98-104.

31.

[Current update on PCKS9 inhibitors].

Gencer B, Nanchen D, Collet TH, Rodondi N, Mach F.

Rev Med Suisse. 2018 Feb 28;14(596):482-486. French.

PMID:
29489129
32.

So low… so far so good: neurocognitive impact of lowering LDL-C levels with PCSK9 inhibitors.

Gencer B, Mach F.

Eur Heart J. 2018 Feb 1;39(5):382-384. doi: 10.1093/eurheartj/ehx742. No abstract available.

PMID:
29346544
33.

Impact of long distance rowing on biological health: A pilot study.

Frias MA, Virzi J, Golaz O, Gencer B, Mach F, Vuilleumier N.

Clin Biochem. 2018 Feb;52:142-147. doi: 10.1016/j.clinbiochem.2017.11.018. Epub 2017 Dec 2.

PMID:
29198760
34.

Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.

Satta N, Pagano S, Montecucco F, Gencer B; Swiss HIV Cohort Study, Mach F, Kaiser L, Calmy A, Vuilleumier N.

J Infect. 2018 Feb;76(2):186-195. doi: 10.1016/j.jinf.2017.11.008. Epub 2017 Dec 14.

PMID:
29198606
35.

Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.

Klingenberg R, Aghlmandi S, Liebetrau C, Räber L, Gencer B, Nanchen D, Carballo D, Akhmedov A, Montecucco F, Zoller S, Brokopp C, Heg D, Jüni P, Marti Soler H, Marques-Vidal PM, Vollenweider P, Dörr O, Rodondi N, Mach F, Windecker S, Landmesser U, von Eckardstein A, Hamm CW, Matter CM, Lüscher TF.

Eur Heart J. 2017 Dec 14;38(47):3493-3502. doi: 10.1093/eurheartj/ehx640.

PMID:
29155984
36.

Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.

Gencer B, Koskinas KC, Räber L, Karagiannis A, Nanchen D, Auer R, Carballo D, Carballo S, Klingenberg R, Heg D, Matter CM, Lüscher TF, Rodondi N, Mach F, Windecker S.

J Am Heart Assoc. 2017 Nov 9;6(11). pii: e006537. doi: 10.1161/JAHA.117.006537.

37.

La télémédecine : nouvel outil dans la prise en charge des patients avec insuffisance cardiaque.

Gencer B, Mach F, Burnand B.

Rev Med Suisse. 2016 Dec 7;12(542):2136. French. No abstract available.

PMID:
28700168
38.

Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort.

Aghlmandi S, Schärer N, Heg D, Räber L, Zwahlen M, Gencer B, Nanchen D, Carballo D, Carballo S, Jüni P, von Eckardstein A, Landmesser U, Rodondi N, Mach F, Windecker S, Matter CM, Lüscher TF, Klingenberg R.

Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):522-531. doi: 10.1177/2048872617706480. Epub 2017 Apr 20.

PMID:
28425755
39.

Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update.

Floriani C, Gencer B, Collet TH, Rodondi N.

Eur Heart J. 2018 Feb 14;39(7):503-507. doi: 10.1093/eurheartj/ehx050.

40.

Lipoprotein(a): the revenant.

Gencer B, Kronenberg F, Stroes ES, Mach F.

Eur Heart J. 2017 May 21;38(20):1553-1560. doi: 10.1093/eurheartj/ehx033. Review.

PMID:
28329241
41.

Multi-organ injuries due to a lightning strike: a case report highlighting the importance of a multi-disciplinary approach.

Tadler M, Rüegg E, Niquille M, Gencer B, Gautschi OP, Pittet-Cuénod B, Modarressi A.

Case Reports Plast Surg Hand Surg. 2017 Jan 6;4(1):1-4. doi: 10.1080/23320885.2016.1275646. eCollection 2017.

42.

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.

Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF.

Eur Heart J. 2017 Mar 14;38(11):814-824. doi: 10.1093/eurheartj/ehw582.

43.

Does Retinal Neurodegeneration Seen in Diabetic Patients Begin in the Insulin Resistance Stage?

Arıkan S, Erşan İ, Eroğlu M, Yılmaz M, Tufan HA, Gencer B, Kara S, Aşık M.

Turk J Ophthalmol. 2016 Dec;46(6):264-269. doi: 10.4274/tjo.68888. Epub 2016 Dec 1.

44.

Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.

Klingenberg R, Aghlmandi S, Räber L, Gencer B, Nanchen D, Heg D, Carballo S, Rodondi N, Mach F, Windecker S, Jüni P, von Eckardstein A, Matter CM, Lüscher TF.

Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):129-138. doi: 10.1177/2048872616684678. Epub 2016 Dec 28.

PMID:
28029055
45.

Repeatability of contrast sensitivity testing in patients with age-related macular degeneration, glaucoma, and cataract.

Kara S, Gencer B, Ersan I, Arikan S, Kocabiyik O, Tufan HA, Comez A.

Arq Bras Oftalmol. 2016 Sep-Oct;79(5):323-327. doi: 10.5935/0004-2749.20160092.

46.

New concepts in the management of dyslipidaemiaa.

Gencer B, Rodondi N, Mach F.

Swiss Med Wkly. 2016 Nov 12;146:w14378. doi: 10.4414/smw.2016.14378. eCollection 2016.

47.

[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)].

Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S.

G Ital Cardiol (Rome). 2016 Oct;17(10):831-872. doi: 10.1714/2464.25804. Italian. No abstract available.

PMID:
27869901
48.

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.

Landmesser U, Chapman MJ, Farnier M, Gencer B, Gielen S, Hovingh GK, Lüscher TF, Sinning D, Tokgözoglu L, Wiklund O, Zamorano JL, Pinto FJ, Catapano AL; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS).

Eur Heart J. 2017 Aug 1;38(29):2245-2255. doi: 10.1093/eurheartj/ehw480. No abstract available. Erratum in: Eur Heart J. 2017 Jan 21;:.

PMID:
27789571
49.

Reply.

Erşan I, Battal F, Aylanç H, Kara S, Arikan S, Tekin M, Gencer B, Tufan HA.

J AAPOS. 2016 Oct;20(5):469-470. doi: 10.1016/j.jaapos.2016.07.224. Epub 2016 Sep 21. No abstract available.

PMID:
27664847
50.

Non-invasive assessment of corneal and conjunctival deterioration in soft contact lens users using anterior segment optical coherence tomography.

Ersan I, Arikan S, Kara S, Gencer B, Koklu A, Tufan HA.

Clin Exp Optom. 2016 Nov;99(6):564-567. doi: 10.1111/cxo.12363. Epub 2016 Mar 29.

Supplemental Content

Loading ...
Support Center